InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Bradway Robert A, Chief Executive Officer. Officer active across 1 companies, notably AMGEN INC. In total, 7 reports have been published. The latest transaction was filed on 5 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€451,8272,017 shares@ €224.00930.0003% mcap9.5% of flow
Common Stock
SEC:0001127602-22-013868:0·
013,781 shares0
Common Stock
SEC:0001127602-22-013339:0·
€602,9502,547 shares@ €236.72930.0003% mcap12.6% of flow
Common Stock
SEC:0001127602-22-012758:0·
€4m17,481 shares@ €212.49570.0021% mcap77.9% of flow
Common Stock
SEC:0001127602-22-010185:0·
034,964 shares0
Common Stock
SEC:0001127602-22-008130:0·
013,280 shares0
Common Stock
SEC:0001127602-21-015045:0·
013,280 shares0
Common Stock
SEC:0001127602-21-015045·
7 of 7 declarations
About Bradway Robert A
Robert A. Bradway is Chairman, CEO, and President of Amgen Inc. He is responsible for the strategic and operational leadership of the company. With extensive experience in the biopharmaceutical sector, he plays a key role in decision-making that influences the company's performance and growth.
